New Indication: Dabrafenib + trametinib for bRAF V600E mutant glioma
|New Indication: Dabrafenib + trametinib for bRAF V600E mutant glioma|
Lancet Oncol. 2022; 23(1):53-64.
Wen PY, et al. Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial
Reviewed by Hasan Cagri Yildirim, MD on Sep 30, 2021
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.